Our Platform   Patents Our proprietary MolecularBreeding™ directed evolution technologies and our protein modification capabilities are dynamically illustrated by the animations in this section. >> Protecting our intellectual capital is of vital importance to us. Maxygen owns over 60 issued patents in the U.S. and abroad covering various formats of our directed molecular evolution technologies. >>     Publications Articles by our scientists have appeared in many of the world's leading scientific publications, offering important validation from the scientific community of the strength of our technology and the contributions of our people. >>